Leadership Team

PathForcedx is led by an executive team that has wide-ranging experience in clinical diagnostics, healthcare services, entrepreneurship and information technology.

Gregory S. Henderson, MD, PhD
Gregory S. Henderson, MD, PhD
Founder and President

Dr. Henderson received his MD and PhD degrees at Vanderbilt University. He completed his fellowship as a NIH Medical Scientist Program Fellow, specializing in breast, gynecologic and oncologic pathology at Vanderbilt University Medical Center.

He has been practicing medicine in the Puget Sound region since 2007, and currently serves on the hospital Board of Trustees at Harrison Medical Center. His previous experience and positions include Partner and President of Pacific Pathology Partners, and medical staff member of Harrison Medical Center.

Dr. Henderson’s passion and interests focus on the utilization of new innovations such as digital pathology to advance the access to quality diagnostics in the developed and developing world. He is the Founder and President of PathForcedx, with the goal of providing digital pathology medical services globally. PathForcedx is actively involved in providing diagnostic services to Haiti and is expanding to other countries that otherwise do not have the medical infrastructure to diagnose patients.

Keith J. Kaplan, MD
Keith J. Kaplan, MD
Founder

Dr. Kaplan practices Pathology and serves as the Chief Information Officer (CIO) of the Carolinas Pathology Group, Celligent Diagnostics and Diligent Billing and Management. As CIO, Dr. Kaplan is responsible for all aspects of informatics strategies, operations, and projects and processes that encompass laboratory, healthcare and research information systems for Carolinas Pathology Group.

Dr. Kaplan is a member of the College of American Pathologists, American Society of Clinical Pathology, American Society of Cytopathology, and the American Pathology Foundation. He also serves as an Executive Board Member of the Digital Pathology Association.

Dr. Kaplan’s specialties include gastrointestinal and hepatic pathology, as well as cytopathology and pathology informatics. His research interests also include gastrointestinal and hepatobiliary pathology, hyperspectral imaging, image analysis and the use of Web 2.0 tools in pathology.

Matthew C. Watson, MBA
Matthew C. Watson, MBA
Chief Executive Officer

Matt is a seasoned healthcare executive with 28 years of experience in clinical diagnostics, both working with pathologists and pathology-related companies. His prior experience includes Co-founder and CEO of PathCentral, a company that provides a wide range of technology-based solutions and services, including digital pathology, to community pathologists. PathCentral’s laboratory unit was acquired by a national diagnostics company in 2013.

Matt also previously served as Vice President of Operations for US Labs (now LabCorp), one of the nation’s fastest-growing cancer diagnostics laboratory. He also held the position as Director of Business Development for ChromaVision Medical Systems, Inc. (now Clarient, a division of GE), pioneering the clinical application of digital pathology. He received a B.A. in Biology from Eastern Connecticut State University and an MBA from the University of Hartford.

Miwa Monji, MBA
Miwa Monji, MBA
Commercialization Consultant

Miwa Monji brings over eleven years of healthcare information technology experience from start-ups to large corporations with a background spanning strategic planning, product management, marketing and operations. As Implementation Manager at Clarity, Miwa is responsible for accelerating growth and driving adoption of software-as-a-service (SaaS) solutions within hospitals, integrated delivery systems and accountable care organizations. Prior to joining PathForcedx, Miwa was an executive at LabCorp marketing a wide range of clinical laboratory and speciality testing. Miwa earned a Technology Management MBA from the University of Washington.